| Literature DB >> 30577490 |
Xiao Wen Mao1, Lawrence B Sandberg2, Daila S Gridley3, E Clifford Herrmann4, Guangyu Zhang5, Ravi Raghavan6, Roman A Zubarev7,8, Bo Zhang9,10, Louis S Stodieck11, Virginia L Ferguson12, Ted A Bateman13, Michael J Pecaut14.
Abstract
There is evidence that spaceflight poses acute and late risks to the central nervous system. To explore possible mechanisms, the proteomic changes following spaceflight in mouse brain were characterized. Space Shuttle Atlantis (STS-135) was launched from the Kennedy Space Center (KSC) on a 13-day mission. Within 3⁻5 h after landing, brain tissue was collected to evaluate protein expression profiles using quantitative proteomic analysis. Our results showed that there were 26 proteins that were significantly altered after spaceflight in the gray and/or white matter. While there was no overlap between the white and gray matter in terms of individual proteins, there was overlap in terms of function, synaptic plasticity, vesical activity, protein/organelle transport, and metabolism. Our data demonstrate that exposure to the spaceflight environment induces significant changes in protein expression related to neuronal structure and metabolic function. This might lead to a significant impact on brain structural and functional integrity that could affect the outcome of space missions.Entities:
Keywords: brain; microgravity; proteomics; spaceflight
Mesh:
Year: 2018 PMID: 30577490 PMCID: PMC6337482 DOI: 10.3390/ijms20010007
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Spaceflight induced alterations to the proteomic profile in the white matter.
| Symbol | Entrez Gene Name | Expr | Expr Log Ratio | Location | Type(s) |
|---|---|---|---|---|---|
| ARG1 | arginase 1 | 0.037 | 3.742 | Cytoplasm | enzyme |
| CACNA2D1 | calcium voltage-gated channel auxiliary subunit alpha2delta 1 | 0.024 | 2.244 | Plasma Membrane | ion channel |
| PPFIA3 | PTPRF interacting protein alpha 3 | 0.025 | 2.189 | Plasma Membrane | phosphatase |
| PITPNA | phosphatidylinositol transfer protein alpha | 0.010 | 1.328 | Cytoplasm | transporter |
| MYO5A | myosin VA | 0.034 | 1.304 | Cytoplasm | enzyme |
| DYNLL2 | dynein light chain LC8-type 2 | 0.040 | 1.152 | Cytoplasm | other |
| VPS35 | VPS35, retromer complex component | 0.046 | −1.164 | Cytoplasm | transporter |
| GAPDH | glyceraldehyde-3-phosphate dehydrogenase | 0.015 | −1.478 | Cytoplasm | enzyme |
| MBP | myelin basic protein | 0.003 | −2.536 | Extracellular Space | other |
Spaceflight induced alterations to the proteomic profile in the gray matter.
| Symbol | Entrez Gene Name | Expr | Expr Log Ratio | Location | Type(s) |
|---|---|---|---|---|---|
| QDPR | quinoid dihydropteridine reductase | 0.0229 | 2.458 | Cytoplasm | enzyme |
| DNM3 | dynamin 3 | 0.00186 | 1.781 | Cytoplasm | enzyme |
| ACAT1 | acetyl-CoA acetyltransferase 1 | 0.0000214 | 1.637 | Cytoplasm | enzyme |
| DNAJC5 | DnaJ heat shock protein family (Hsp40) member C5 | 0.00702 | 1.501 | Plasma Membrane | other |
| SH3GL2 | SH3 domain containing GRB2-like 2, endophilin A1 | 0.0136 | 1.377 | Plasma Membrane | enzyme |
| RAP1GDS1 | Rap1 GTPase-GDP dissociation stimulator 1 | 0.0284 | 1.363 | Cytoplasm | other |
| DNM1L | dynamin 1-like | 0.0069 | 1.284 | Cytoplasm | enzyme |
| CNP | 2′,3′-cyclic nucleotide 3′ phosphodiesterase | 0.000816 | 1.261 | Cytoplasm | enzyme |
| YWHAE | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein epsilon | 0.00989 | 1.261 | Cytoplasm | other |
| ACTN1 | actinin alpha 1 | 0.0308 | 1.254 | Cytoplasm | transcription regulator |
| ATP6V0A1 | ATPase H+ transporting V0 subunit a1 | 0.00028 | 1.191 | Cytoplasm | transporter |
| IMMT | inner membrane mitochondrial protein | 0.00436 | 1.154 | Cytoplasm | other |
| NEFL | neurofilament light | 0.00557 | 1.153 | Cytoplasm | other |
| ENO2 | enolase 2 | 0.0281 | 1.123 | Cytoplasm | enzyme |
| STX1A | syntaxin 1A | 0.00859 | 1.074 | Cytoplasm | transporter |
| UQCRB | ubiquinol-cytochrome c reductase binding protein | 0.0447 | −1.059 | Cytoplasm | enzyme |
| SEC22B | SEC22 homolog B, vesicle trafficking protein (gene/pseudogene) | 0.00601 | −2.709 | Cytoplasm | other |
Spaceflight induced changes in white and gray matter proteins indicative of functional deficits.
| Region | Categories | Diseases or Functions Annotation | Activation | |
|---|---|---|---|---|
|
| Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance | formation of cellular protrusions | 1.69 × 10−3 | −1.982 |
| Organismal Survival | organismal death | 3.76 × 10−2 | −1.156 | |
| Cellular Assembly and Organization, Cellular Function and Maintenance | organization of cytoplasm | 6.40 × 10−5 | −1.154 | |
| Cellular Assembly and Organization, Cellular Function and Maintenance | microtubule dynamics | 9.47 × 10−5 | −1.154 | |
| Tissue Morphology | quantity of cells | 3.44 × 10−2 | −0.44 | |
| Cell Death and Survival | apoptosis | 4.26 × 10−2 | 0.003 | |
| Cell Death and Survival | necrosis | 1.41 × 10−2 | 0.014 | |
| Cell Death and Survival | cell death of tumor cell lines | 4.40 × 10−3 | 0.028 | |
| Cell Death and Survival | cell death | 1.41 × 10−2 | 0.166 | |
| Cell Death and Survival | apoptosis of tumor cell lines | 3.86 × 10−2 | 0.176 | |
| Lipid Metabolism, Molecular Transport, Small Molecule Biochemistry | concentration of lipid | 7.47 × 10−3 | 0.333 | |
|
| Organismal Survival | organismal death | 1.22 × 10−3 | −3.257 |
| Organismal Injury and Abnormalities | organ degeneration | 1.46 × 10−5 | −2.186 | |
| Cellular Compromise | degeneration of cells | 1.36 × 10−4 | −1.982 | |
| Developmental Disorder | growth failure | 1.45 × 10−2 | −1.982 | |
| Neurological Disease | neurodegeneration | 8.36 × 10−5 | −1.981 | |
| Cell Death and Survival | necrosis | 1.84 × 10−5 | −1.6 | |
| Cell Death and Survival | apoptosis | 5.78 × 10−3 | −1.404 | |
| Cell Death and Survival | neuronal cell death | 2.96 × 10−3 | −0.958 | |
| Molecular Transport | transport of molecule | 9.80 × 10−3 | −0.722 | |
| Cell Death and Survival | cell viability | 1.48 × 10−2 | 0.555 | |
| Infectious Diseases | infection by HIV-1 | 2.45 × 10−3 | 1.98 | |
| Infectious Diseases | Viral Infection | 1.12 × 10−2 | 2.2 |